ethyl 2,5-dihydroxycinnamate has been researched along with erbstatin in 1 studies
| Studies (ethyl 2,5-dihydroxycinnamate) | Trials (ethyl 2,5-dihydroxycinnamate) | Recent Studies (post-2010) (ethyl 2,5-dihydroxycinnamate) | Studies (erbstatin) | Trials (erbstatin) | Recent Studies (post-2010) (erbstatin) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 145 | 0 | 2 |
| Protein | Taxonomy | ethyl 2,5-dihydroxycinnamate (IC50) | erbstatin (IC50) |
|---|---|---|---|
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 3.719 | |
| Vif | Human immunodeficiency virus 1 | 1.72 | |
| Tat | Human immunodeficiency virus 1 | 10.97 | |
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.4621 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.72 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honma, Y; Hozumi, M; Kawada, M; Tawara, J; Tsuji, T; Umezawa, K; Wang, JY | 1 |
1 review(s) available for ethyl 2,5-dihydroxycinnamate and erbstatin
| Article | Year |
|---|---|
Inhibition of Abelson oncogene function by erbstatin analogues.
Topics: Abelson murine leukemia virus; Animals; Cell Differentiation; Cell Line, Transformed; Cell Survival; Cell Transformation, Viral; Cinnamates; Genes, abl; Humans; Hydroquinones; Oncogene Proteins v-abl; Protein-Tyrosine Kinases | 1993 |